Company
Mirati Therapeutics, Inc. (0001576263)
Standardized SEC financial data for Mirati Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001576263 · Pharmaceutical Preparations.
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-82.8%
Return on equity
-74.3%
Free cash flow
-$575.4M
Current ratio
6.96×
EPS (diluted)
$-13.18
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $12.9M | $3.3M | $13.4M | $72.1M | $12.4M |
| R&D expense |
Balance sheet
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $107.7M | $32.7M | $46.9M | $886.2M | $413.7M | $235.9M |
| Inventory |
Cash flow
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$64.7M | -$70.1M | -$147.7M | -$271.5M | -$388.8M | -$570.6M |
| Capital expenditures |
Get 0001576263 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001576263/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001576263/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"